ORIGINAL RESEARCH
Published on 27 Jan 2025
An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer
doi 10.3389/fonc.2025.1491848
- 541 views